Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stephens

Showing results (1001-1010 of 1,072) with videos related to

Pageof 108
Sort By:
The Journal of Urology|November 21, 2015
Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research NetworkJames W Griffith, Alisa J Stephens-Shields, Xiaoling Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Science Translational Medicine|July 2, 2010
Genomic architecture characterizes tumor progression paths and fate in breast cancer patientsHege G Russnes, Hans Kristian Moen Vollan, Ole Christian Lingjærde, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic ProfilingAlexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Cancer Discovery|September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 InhibitorsHaiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled TrialGlenn R Cunningham, Susan S Ellenberg, Shalender Bhasin, et al.
Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.
Anesthesia and Analgesia|August 25, 2022
Barriers to Quality Perioperative Care Delivery in Low- and Middle-Income Countries: A Qualitative Rapid Appraisal StudyGillian J Bedwell, Priyanthi Dias, Lina Hahnle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2013
A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinomaJeffrey S Ross, Kai Wang, Laurie M Gay, et al.
The Lancet. Diabetes & Endocrinology|October 28, 2018
Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone TrialsShalender Bhasin, Susan S Ellenberg, Thomas W Storer, et al.
Pageof 108

Showing results (1001-1010 of 1,072) with videos related to

Sort By:
Pageof 108
The Journal of Urology|November 21, 2015
Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research NetworkJames W Griffith, Alisa J Stephens-Shields, Xiaoling Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Science Translational Medicine|July 2, 2010
Genomic architecture characterizes tumor progression paths and fate in breast cancer patientsHege G Russnes, Hans Kristian Moen Vollan, Ole Christian Lingjærde, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic ProfilingAlexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Cancer Discovery|September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 InhibitorsHaiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled TrialGlenn R Cunningham, Susan S Ellenberg, Shalender Bhasin, et al.
Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.
Anesthesia and Analgesia|August 25, 2022
Barriers to Quality Perioperative Care Delivery in Low- and Middle-Income Countries: A Qualitative Rapid Appraisal StudyGillian J Bedwell, Priyanthi Dias, Lina Hahnle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2013
A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinomaJeffrey S Ross, Kai Wang, Laurie M Gay, et al.
The Lancet. Diabetes & Endocrinology|October 28, 2018
Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone TrialsShalender Bhasin, Susan S Ellenberg, Thomas W Storer, et al.
Pageof 108